Trial intelligence / Profile preview

Endotoxemia before Fluenz immune response study

NL-OMON42371Not yet recruiting

Sponsor
Radboud University Medical Center
Start
Jan 2016
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Randomised trial in influenza comparing LPS then Fluenz with Placebo then Fluenz (2 arms). Primary endpoint: Local inflammatory response in nasal wash. Planned start Jan 2016; status: not yet recruiting.

02

Drugs

live attenuated influenza vaccinelipopolysaccharide endotoxin
03

Conditions

influenza

Beyond the preview

Go deeper on NL-OMON42371.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON42371.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call